Table 4.
Trimester-specific prevalence of perinatal outcomes according to the thyroid function.
| Pregnancy outcomes | First trimester (<13 weeks, n = 2208) | Second trimester (13–20 weeks, n = 5965) | ||
|---|---|---|---|---|
| Euthyroid (n = 2107) | IMH (n = 101) | Euthyroid (n = 5724) | IMH (n = 241) | |
| LBWa | 63 (2.99) | 3 (2.97) | 147 (2.57) | 8 (3.32) |
| Macrosomia | 109 (5.17) | 11 (10.89) | 348 (6.08) | 20 (8.30) |
| SGAb | 91 (4.32) | 2 (1.98) | 253 (4.42) | 11 (4.56) |
| LGAc | 264 (12.53) | 19 (18.81) | 764 (13.35) | 44 (18.26) |
| Preterm delivery | 93 (4.41) | 2 (1.98) | 234 (4.09) | 14 (5.81) |
| Hypertensive disorders of pregnancy | 57 (2.71) | 4 (3.96) | 165 (2.88) | 16 (6.64) |
| Preeclampsia | 15 (0.71) | 2 (1.98) | 56 (0.98) | 2 (0.83) |
| GDMd | 260 (12.97) | 18 (18.95) | 742 (13.42) | 41 (17.90) |
| placenta previa | 19 (0.90) | 1 (0.99) | 41 (0.72) | 2 (0.83) |
| Placenta abruption | 10 (0.47) | 1 (0.99) | 20 (0.35) | 3 (1.24) |
aLow birth weight; bsmall for gestational age of infant; clarge for gestational age of infant; dgestational diabetes mellitus.
This work is licensed under a